M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors

Phase 1

Completed

Conditions: Solid Tumors

Interventions: Drug: Topotecan
Drug: Ifosfamide
Drug: Carboplatin

First Posted Date: 2007-07-18

Last Posted Date: 2012-08-01

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 2

Registration Number: NCT00502892

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Busulfan and Fludarabine in Patients With AML and MDS

Phase 2

Completed

Conditions: Leukemia

Interventions: Drug: Busulfan
Drug: Fludarabine

First Posted Date: 2007-07-18

Last Posted Date: 2012-05-28

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 200

Registration Number: NCT00502905

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

3-Dimensional Form and Soft Tissue Biomechanics of the Breast

Terminated

Conditions: Breast Cancer

Interventions: Procedure: 3-D Optical Surface Scan
Procedure: Mechanical Testing
Procedure: Cutaneous Ultrasound
Procedure: Breast MRI and/or CT

First Posted Date: 2007-07-18

Last Posted Date: 2012-02-22

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 45

Registration Number: NCT00502814

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Smoking Cessation for HIV/AIDS Patients

Not Applicable

Completed

Conditions: Human Immunodeficiency Virus

Interventions: Behavioral: Cell Phone Intervention
Other: Recommended Standard of Care

First Posted Date: 2007-07-18

Last Posted Date: 2016-02-26

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 706

Registration Number: NCT00502827

Locations: 🇺🇸
Thomas Street Clinic, Houston, Texas, United States
🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers

Phase 2

Completed

Conditions: Familial Adenomatous Polyposis

Interventions: Drug: Celecoxib
Procedure: Colonoscopy Biopsy

First Posted Date: 2007-07-18

Last Posted Date: 2023-02-13

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 51

Registration Number: NCT00503035

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Genetic Study of Chronic Lymphocytic Leukemia Families

Conditions: Leukemia

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-07-18

Last Posted Date: 2019-05-09

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 4000

Registration Number: NCT00503256

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Exercise Program for Adolescents and Young Adults With Cancer

Not Applicable

Completed

Conditions: Leukemia
Lymphoma

Interventions: Behavioral: Exercise program
Behavioral: Questionnaires

First Posted Date: 2007-07-18

Last Posted Date: 2011-10-17

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 37

Registration Number: NCT00502749

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

In Vivo Confocal Imaging of Oral Mucosa

Completed

Conditions: Oral Tumors

Interventions: Procedure: Reflectance Confocal Imaging

First Posted Date: 2007-07-17

Last Posted Date: 2012-08-01

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 12

Registration Number: NCT00502125

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Evaluation of a Multispectral Vision Enhancement System for Assessment of Oral Mucosal Lesions

Completed

Conditions: Oral Cancer

Interventions: Behavioral: Interview

First Posted Date: 2007-07-17

Last Posted Date: 2012-07-30

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 45

Registration Number: NCT00502580

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Quality of Life Study for Pediatric and Adult Patients Undergoing Hyperthermic Peritoneal Perfusion With Cisplatin

Completed

Conditions: Peritoneal Neoplasms

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-07-17

Last Posted Date: 2018-10-24

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 48

Registration Number: NCT00502177

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy